Latest AUTL reports update at 2024-05-11: 2023 ∙ 2022 ∙ 2021

Autolus Therapeutics plc AUTL

$ 4.17 1.46%

Autolus Therapeutics plc Financial Statements 2011-2024 | AUTL

Annual Financial Statements Autolus Therapeutics plc

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	1.09 B	299 M	270 M	332 M	352 M	1.08 B	43.4 M	-	-	-	-	-	-
Shares	174 M	95 M	72.1 M	51.6 M	43.1 M	39.4 M	13.8 M	-	-	-	-	-	-
Historical Prices	6.25	3.15	3.74	6.44	8.18	27.4	-	-	-	-	-	-	-
Net Income	-208 M	-149 M	-142 M	-142 M	-124 M	-20.6 M	-19.7 M	-12.6 M	-	-	-	-	-
Revenue	-	-	-	242 K	2.91 M	1.41 M	1.69 M	1.21 M	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-180 M	-168 M	-165 M	-168 M	-146 M	-25 M	-23.4 M	-	-	-	-	-	-
Interest Expense	45.1 M	8.9 M	1.1 M	1.35 M	4.51 M	1.1 M	-46 K	-26 K	-	-	-	-	-
EBITDA	-173 M	-161 M	-157 M	-162 M	-141 M	-23.3 M	-22.4 M	-13.9 M	-	-	-	-	-
Operating Expenses	-	-	-	-	145 M	58.9 M	25.1 M	15.6 M	-	-	-	-	-
General and Administrative Expenses	46.7 M	31.9 M	31.9 M	35 M	39.5 M	22.8 M	9.1 M	5.15 M	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Autolus Therapeutics plc

	2023-Q3	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	174 M	-	91.2 M	-	-	-	-	-	62.4 M	-	52.1 M	52 M	49.9 M	-	44.5 M	43.6 M	39.5 M	39.4 M	39.2 M	29.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-45.8 M	-	-42.8 M	-	-	-	-	-	-33.3 M	-	-37.3 M	-32 M	-29.9 M	-	-27.2 M	-28.5 M	-27.2 M	-20.6 M	-12.9 M	-7.65 M	-16.7 M	-7.52 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	269 K	-	-	293 K	338 K	-	297 K	338 K	1.96 M	296 K	307 K	443 K	-	231 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-47.8 M	-	-43.5 M	-	-	-	-	-	-39.9 M	-	-42.7 M	-39.5 M	-38.6 M	-	-35.6 M	-37.2 M	-30.2 M	-25 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	5.01 M	-	1.85 M	-	-	-	-	-	838 K	-	-2.51 M	525 K	4.48 M	-	3.26 M	4.38 M	-984 K	1.1 M	-	-	-	-685 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-46.4 M	-	-41.7 M	-	-	-	-	-	-38.2 M	-	-41.2 M	-38.3 M	-37.3 M	-	-34.5 M	-36.1 M	-28.5 M	-24.4 M	300 K	500 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	35.6 M	37.2 M	-	25 M	17.1 M	16.5 M	-	8.42 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	10.6 M	-	8.23 M	-	-	-	-	-	8.74 M	-	9.84 M	8.51 M	7.61 M	-	8.6 M	11.4 M	9.56 M	7.59 M	7.27 M	8.1 M	-	3.08 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency